WCN26-9066 CAUSAL IMPACT OF ABCG2-RELATED SNPS ON RENAL FUNCTION VIA SERUM URIC ACID: A MENDELIAN RANDOMIZATION STUDY IN A JAPANESE COHORT

Read full text Summarise with VIRAT
Authors: Takehisa Yamada, Satoshi Wakita, Tetsuya Kashiwagi, Yukinao Sakai, Shinichi Namba, Koichi Matsuda, Hiroki Yamaguchi, Masato Iwabu, Yasunobu Nagata
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The clinical appropriateness of urate-lowering therapy in patients with hyperuricemia and chronic kidney disease (CKD) remains controversial due to the bidirectional relationship between serum uric acid (sUA) and renal function. It is unclear whether elevated sUA contributes to renal impairment or if reduced kidney function leads to hyperuricemia. Ethical limitations hinder prospective interventional studies to resolve this issue. Although recent guidelines, such as those from KDIGO, suggest limited evidence supporting urate-lowering therapy for CKD prevention, genetic predisposition—particularly in populations with high prevalence of urate transporter variants—offers a unique opportunity to infer causality through Mendelian Randomization (MR).

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Genetic Associations and Epidemiology Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105162–105162
Publication date
25 March 2026
Language
EN